DTE
43
5
MCD
52
-5
WMB
68
2
XOM
42
-6
LMT
30
-2
AME
74
-4
CVS
41
-4
AAPL
40
-6
DVN
14
-6
PG
50
2
PLD
45
-5
CSX
57
-4
STZ
52
-6
TMO
42
-6
ORCL
63
-4
CAG
24
-3
REGN
38
-2
CB
57
2
ADBE
47
-9
SHW
62
-6
DTE
43
5
MCD
52
-5
WMB
68
2
XOM
42
-6
LMT
30
-2
AME
74
-4
CVS
41
-4
AAPL
40
-6
DVN
14
-6
PG
50
2
PLD
45
-5
CSX
57
-4
STZ
52
-6
TMO
42
-6
ORCL
63
-4
CAG
24
-3
REGN
38
-2
CB
57
2
ADBE
47
-9
SHW
62
-6
Financhill
Back

Roivant Sciences Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
34

ROIV
Roivant Sciences

Last Price:
11.14
Seasonality Move:
19.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Roivant Sciences Price Quote

$11.14
-0.06 (-0.54%)
(Updated: November 18, 2024 at 12:30 PM ET)

Roivant Sciences Key Stats

Sell
34
Roivant Sciences (ROIV) is a Sell
Day range:
$11.14 - $11.61
52-week range:
$8.56 - $13.06
Dividend yield:
0%
P/E ratio:
2.23
P/S ratio:
59.70
P/B ratio:
1.58%
Volume:
8.4M
Avg. volume:
4.2M
1-year change:
23.48%
Market cap:
$8.6B
Revenue:
$124.8M
EPS:
$5.56

How Much Does Roivant Sciences Make?

Is Roivant Sciences Growing As A Company?

  • What Is Roivant Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.55%
  • What Is Roivant Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Roivant Sciences Stock Price Performance

  • Did Roivant Sciences Stock Go Up Last Month?
    Roivant Sciences share price went down by -5.72% last month
  • Did ROIV's Share Price Rise Over The Last Year?
    ROIV share price rose by 23.48% over the past 1 year

What Is Roivant Sciences 52-Week High & Low?

Roivant Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Roivant Sciences?

  • How Much Debt Does Roivant Sciences Have?
    Total long term debt quarterly is $323.7M
  • How Much Cash Does Roivant Sciences Have?
    Cash and short term investments quarterly total is $5.7B
  • What Is Roivant Sciences’s Book Value Per Share?
    Book value per share is 7.35

Is Roivant Sciences Cash Flow Positive?

  • What Is ROIV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$708.2M
  • What Is Roivant Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$248.7M
  • What Is Roivant Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $5.2B

Roivant Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    ROIV return on invested capital is 100.04%
  • What Is Roivant Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is 93.84%
  • What Is ROIV Return On Equity?
    ROE is a measure of profitability and is 109.69%

Roivant Sciences Earnings Date & Stock Price

Roivant Sciences Competitors

  • Who Are Roivant Sciences's Competitors?
    Below is a list of companies who compete with Roivant Sciences or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • NuCana PLC (NCNA)
    • Organon & Co (OGN)
    • Verona Pharma PLC (VRNA)

Roivant Sciences Dividend Yield

Roivant Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -56.32%
Revenue: 154.96% -43.14%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 15.92
Upside from Last Price: 42.11%

Major Shareholders

  • How many ROIV shares are owned by institutional investors?
    925M ROIV shares are owned by institutional investors
  • How many ROIV shares are owned by insiders?
    101.9M ROIV shares are owned by insiders